Anetumab ravtansine, CAS 1375258-01-7

Product Description: Anetumab ravtansine (BAY 94-9343) is a selective and highly potent antibody-drug conjugate (ADC) to target maytansinoid tubulin. Anetumab ravtansine consists of a human anti-mesothelin antibody conjugated to the maytansinoid tubulin inhibitor DM4. Anetumab ravtansine shows antitumor efficacy correlated with the amount of mesothelin expressed in patient-derived xenograft tumor models[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Golfier S, et al. Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect. Mol Cancer Ther. 2014 Jun;13(6):1537-48.

CAS Number: 1375258-01-7

Molecular Weight: N/A

Compound Purity: 99.36

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Antibody-Drug Conjugates (ADCs);Microtubule/Tubulin

• Artikelnummer: MEXHY-141606-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-141606-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK